Iranian Journal of Child Neurology

How to Cite This Article: Taghdiri MM, Nemati H. Infantile Spasm: A Review Article. Iran J Child Neurol. 2014 Summer;8(3): 1-5.

Abstract

Objective
Infantile spasm (IS) is a convulsive disease characterized by brief, symmetric axial muscle contraction (neck, trunk, and/or extremities). IS is a type of seizure that was first described by West in 1841, who witnessed the seizure in his own son. West’s syndrome refers to the classic triad of spasms, characteristic EEG, and neurodevelopmental regression. Most cases involve flexors and extensors,
but either of the types may be involved independently.
IS, as its name implies, most often occurs during the first year of life with an incidence of approximately 1 per 2000-4000 live births. Most, but not all, patients with this disorder have severe EEG abnormalities; this pattern was originally
referred to as hypsarrhythmia by Gibbs and Gibbs. Cases with known etiology or signs of brain damage are considered as symptomatic. The Overall prognosis of the disease is poor. Peak onset age of the epileptic syndrome is 3 to 7 months, which mainly occurs before 2 years of age in 93% of patients. Hypsarrhythmia is the EEG hallmark of IS, which comprised a chaotic, bilaterally asynchronous high-voltage polyspike, and slow wave discharges interspersed with multifocal spikes and slow waves.
Etiological classification is as follows: 1) Symptomatic: with identifiable prenatal, perinatal, and postnatal causes with developmental delay at the presentation time; 2) Cryptogenic: unknown underlying cause, normal development at the onset of spasms, normal neurological exam and neuroimaging, and no abnormality in the metabolic evaluation; 3) Idiopathic: pure functional cerebral dysfunction with complete recovery, no residual dysfunction, normal neuroimaging and normal etiologic evaluation, and normal neurodevelopment.

References

1. Infantile Spasms. In: Jean Aicardi: Disease of Nervous system in childhood. 3th ed. Mac Keith pres; 2009. p. 593-7.
2. Fujii, Oquni H, Hirano Y, Shioda M, Osawa M. A longterm, clinical study on symptomatic infantile spasm with focal features. Brain Dev 2013;35(5):379-85.
3. SankarR, Koh S, Wu J. Menkes JH. Paroxysmal disorders. In: Menkes JH, Sarnat HB,. MariaBL, editors Child neurology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 857-942.
4. Kendall Nash and Joseph Sullivan. Myoclonic seizures and infantile spasms. InSwaiman KF, Ashwal S, Ferriero DM, Schor NF, editors.. Swaiman’s pediatric Neurology: principles and practice. 5th ed. Edinburgh: Elsevier Saunders; 2012. p. 774-89.
5. Paroxysmal Disorders. In: Piña-Garza J. Fenichel’s Clinical Pediatric Neurology. 7th ed. Elsevier Saunders; 2013. p. 1-46.
6. Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011;45(6):355-67.
7. Manqanno S, Nardello R, Tripi G, Giordano G, Spitaleri C, Manfano GR. West Syndrome Followed by juvenile myoclonic epilepsy: a coincidental occurrence. BMC Neural 2013;13:48.
8. LUX AL. Latest American and European update on infantile spasms. Curr Neural Neurosci Rep 2013;13(3):334.
9. Hrachovy RA, Frost JD Jr. Infantile spasms. Handb Clin Neuro. 2013;111:611-8.
10. Shumiloff NA, Lam WM, Manasco KB. Adrenocorticotropic hormone for the treatment of west syndrome in children. Ann Pharmacother 2013 47(5):744- 54.
11. Wheless JW, Gibson PA, Rosbeck KL, Hardin M, O’Dell C, Whiltemore V. Infantile Spasms (west syndrome):  Update and resources for pediatricians and providers to share with parents. BMC Pediatr. 2012;12:108.
12. Watemberg N. Infantile Spasms: treatment challenges. Curr Treat Options Neural. 2012;14(4): 322-31.
13. Fukui M, Shimakawa S, Tanabe T, Nomura S, Kashiwagi M, Azumakawa K. Partial seizures during ACTH therapy in a cryptogenic West syndrome patient. Brain Dev 2013;Pii:s0387-7604(13)00003-x.
14. Friedman D, Boqner M, Parker-Menzer K, Dviskyo. Vigabatin for partial- onset seizure treatment in patients with tuberous sclerosis complex. Epilepsy Behav 2013;27(1):118-20.
15. Bilton JY, Sauerwein HC, Wiss SK, Donner EJ, Whiting S, Dooley JM, et al. A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile Spasms. Epilepsia 2012;53(9):1570-6.
16. Pires ME, IIea A, Bourel E, Bellaroine V, Merdariv D, Berquin P. Ketogenic diet for infantile spasms refractory to first-line treatment: An open prospective study. Epilepsy Res 2013; 105(1-2): 189-94.
17. Vykuntaragu KN, Bhat S, Sangay KS, Govindaagu M. Symptomatic West syndrome Secondary to Glucose transporter-1 (GluT1) Deficiency with complete response to 4:1 Ketogenic Diet. Indian J Pediatr 2013. [Epub ahead of print]
18. Taghdiri MM, Comparative effects of Nitrazepam and ACTH on the treatment of infantile Spasms. Iran J Child Neurol 2007;1(4):25-30.
19. Taghdiri MM, Presentation of 60 cases of infantile spasms based on etiology, clinical manifestation, EEG and brain CT scan in Mofid Children’s Hospital. JRehab 2002;3(8- 9);39-42.
20. Taghdiri MM. Report of 40 cases of Tuberous sclerosis in Tehran. Scientific Journal of Hamadan University of Medical sciences 2002;9(1):63-7.
21. Mytinger JR, Joshi S; Pediatric Epilepsy Research Consortium, Section on Infantile Spasms. The current evaluation and treatment of infantile spasms among members of the child Neurology Society. J child Neural 2012;227(10):1289-94.
22. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev 2013;6:CD001770.

How to Cite This Article: Kazemi H, Speckmann EJ, Gorji A. Familial Hemiplegic Migraine and Spreading Depression. Iran J Child Neurol. 2014 Summer;8(3): 6-11.

Abstract
Objective
Familial hemiplegic migraine (FHM) is an autosomal dominantly inherited subtype of migraine with aura, characterized by transient neurological signs and symptoms. Typical hemiplegic migraine attacks start in the first or second decade of life. Some patients with FHM suffer from daily recurrent attacks since childhood. Results from extensive studies of cellular and animal models have indicated that gene mutations in FHM increase neuronal excitability and reduce the threshold for spreading depression (SD). SD is a transient wave of profound neuronal and glial depolarization that slowly propagates throughout the brain tissue and is characterized by a high amplitude negative DC shift. After induction of SD, S218L mutant mice exhibited neurological signs highly reminiscent of clinical attacks in FHM type 1 patients carrying this mutation. FHM1 with ataxia is attributable to specific mutations that differ from mutations that cause pure FHM1 and have peculiar consequences on cerebellar Cav2.1 currents that lead to profound Purkinje cell dysfunction and neuronal loss with atrophy. SD in juvenile rats produced neuronal injury and death. Hormonal factors involved in FHM affect SD initiation and propagation. The data identify SD as a possible target of treatment of FHM. In addition, FHM is a useful model to explore the mechanisms of more common types of migraine.

References

1. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011 (5):457-70.
2. The International Classification of Headache Disorders, 3rd edition (beta version).Headache Classification Committee of the International Headache Society (IHS). Cephalalgia2013;33(9):629-808.
3. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB.A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria.Brain 2002a; 125(Pt 6):1379-91.
4. Kazemi H, Gorji A. Migraine in children and adolescents. Iranian Journal of Child Neurology 2011; 4(4):1-6.
5. Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998; 44(5):731-9.
6. Prayson RA, Wang N. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome: an autopsy report. Arch Pathol Lab Med 1998;122(11):978-81.
7. Steele JG, Nath PU, Burn J, Porteous ME. An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993;33(3):145-8.
8. Haan J, Algra PR, Roos RA. Hereditary cerebral hemorrhage with amyloidosis–Dutch type.Clinical and computed tomographic analysis of 24 cases. Arch Neurol 1990;47(6):649-53.
9. Gunel M, Awad IA, Anson J, Lifton RP.Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. ProcNatlAcadSci USA 1995;92:6620-4.
10. Terwindt GM, Ophoff RA, Lindhout D, Haan J, Halley DJ, Sandkuijl LA, et al. Partial cosegregation of familial hemiplegic migraine and benign familial infantile epileptic syndrome. Epilepsia 1997;38(8):915-21.
11. Bosemani T, Burton VJ, Felling RJ, Leigh R, Oakley C, Poretti A, Huisman TA.Pediatric hemiplegic migraine: Role of multiple MRI techniques in evaluation of reversible hypoperfusion.Cephalalgia2013 Oct 18.[Epub ahead of print].
12. Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001;345:17-24.
13. Thomsen LL, Eriksen MK, Roemer SF, et al. An epidemiological survey of hemiplegic migraine. Cephalalgia 2002b;22(5):361-75.
14. Vahedi K, Depienne C, Le Fort D, Riant F, Chaine P, Trouillard O, et al.Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology 2009 31;72(13):1178-83.
15. Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003;60(4):595-601.
16. van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr Opin Neurol 2007; 20:299–305.
17. Gritz SM, Radcliffe RA. Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models. Hum Genomics 2013;5;7:8.
18. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543–552.
19. Gargus JJ, Tournay A. Novel Mutation Confirms Seizure Locus SCN1A is Also Familial Hemiplegic Migraine Locus FHM3.PediatrNeurol 2007;37:407-410.
20. Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, et al.Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron 2009;61(5):762-73.
21. Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants RR, Ferrari MD. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur J Hum Genet 1998;6(4):297-307.
22. Terwindt GM, Ophoff RA, van Eijk R, Vergouwe MN, Haan J, Frants RR, et al. Dutch Migraine Genetics Research Group. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001;56(8):1028-32.
23. Franceschini A, Vilotti S, Ferrari MD, van den Maagdenberg AM, Nistri A, Fabbretti E. TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PLoS One 2013;8:e52394.
24. Kodangattil JN, Möddel G, Müller, M, Weber W, Gorji A.The inflammatory chemokine CXCL10 modulates synaptic plasticity and neuronal activity in the hippocampus. European Journal of Inflammation 2012;10(3):311-328
25. Leao AAP. Spreading depression of activity in the cerebral cortex. JNeurophysiol 1944; 7: 359–390.
26. Gorji A, Spreading depression: a review of the clinical relevance.Brain Res Brain Res Rev. 2001 Dec;38(1-2):33-60.
27. Somjen GG.Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 2001; 81(3):1065-96.
28. Berger M, Speckmann EJ, Pape HC, Gorji A.Spreading depression enhances human neocortical excitability in vitro. Cephalalgia 2008;28(5):558-62.
29. Ghadiri MK, Kozian M, Ghaffarian N, Stummer W, Kazemi H, Speckmann EJ, et al. Sequential changes in neuronal activity in single neocortical neurons after spreading depression.Cephalalgia 2012;32(2):116-24.
30. Dreier JP, Major S, Pannek HW, Woitzik J, Scheel M, et al. COSBID study group.Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex.Brain 2012;135(Pt 1):259-75.
31. Tokuda S, Kuramoto T, Tanaka K, Kaneko S, Takeuchi IK, Sasa M, et al.The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures. Brain Res 2007;1133(1):168-77.
32. Ayata C, Shimizu-Sasamata M, Lo EH, Noebels JL, Moskowitz MA.Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neurosci 2000;95(3):639-45.
33. van den Maagdenberg AM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca (v)2.1 S218L mice. Ann Neurol 2010;67(1):85-98.
34. Eikermann-Haerter K, Dileköz E, Kudo C, Savitz SI, Waeber C, Baum MJ, et al.Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.J Clin Invest 2009a;119(1):99-109.
35. Eikermann-Haerter K, Yuzawa I, Qin T, Wang Y, Baek K, Kim YR, et al.Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice.J Neurosci 2011;31(15):5755-63.
36. Eikermann-Haerter K, Dileköz E, Kudo C, Savitz SI, Waeber C, Baum MJ, et al.Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 2009b;119(1):99-109.
37. Sachs M, Pape HC, Speckmann EJ, Gorji A.The effect of estrogen and progesterone on spreading depression in rat neocortical tissues.Neurobiol Dis 2007;25(1):27-34.
38. Supcun B, Ghadiri MK, Zeraati M, Stummer W, Speckmann EJ, Gorji A.The effects of titanic stimulation on plasticity of remote synapses in the hippocampus-perirhinal cortex-amygdala network. Synapse2012;66(11):965-74.
39. Eikermann-Haerter K, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C.Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice.Ann Neurol 2009c;66(4):564-8.
40. Freilinger T, Bohe M, Wegener B, Müller-Myhsok B, Dichgans M, Knoblauch H.Expansion of the phenotypic spectrum of the CACNA1A T666M mutation: a family with familial hemiplegic migraine type 1, cerebellar atrophy and mental retardation. Cephalalgia2008;28(4):403-7.
41. Crawford JS, Konkol RJ.Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement.Headache 1997; 37(9):590-3.
42. Candee MS, McCandless RT, Moore KR, Arrington CB, Minich LL, Bale JF Jr.White Matter Lesions in Children and Adolescents With Migraine. Pediatr Neurol 2013. [Epub ahead of print].
43. Jafarian M, Rahimi S, Behnam F, Hosseini M, Haghir H, Sadeghzadeh B, et al.The effect of repetitive spreading depression on neuronal damage in juvenile rat brain. Neurosci 2010;169(1):388-94.
44. Sadeghian H, Jafarian M, Karimzadeh F, Kafami L, Kazemi H, Coulon P, Ghabaee M, Gorji A.Neuronal death by repetitive cortical spreading depression in juvenile rat brain.Exp Neurol 2012;233(1):438-46.
45. Haghir H, Kovac S, Speckmann EJ, Zilles K, Gorji A.Patterns of neurotransmitter receptor distributions following cortical spreading depression.Neurosci 2009;163(4):1340-52.
46. Kaube H, Herzog J, Käufer T, Dichgans M, Diener HC.Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000;55(1):139-41.
47. Ayata C, Jin H, Kudo C, Dalkara T,Moskowitz MA.Suppression of cortical spreading depression in migraineprophylaxis. Ann Neurol 2006;59(4):652–661.
48. Kazemi H, Rahgozar M, Speckmann EJ, Gorji A.Effect of cannabinoid receptor activation on spreading depression.Iran J Basic Med Sci 2012;15(4):926-36.
49. Seghatoleslam M, Ghadiri MK, Ghaffarian N, Speckmann EJ, Gorji A. Cortical spreading depression modulates the caudate nucleus activity.Neuroscience 2014;267C:83-90.
50. Eickhoff M, Kovac S, Shahabi P, Ghadiri MK, Dreier JP, Stummer W, Speckmann EJ, Pape HC, Gorji A. Spreading depression triggers ictaform activity in partially disinhibited neuronal tissues.Exp Neurol. 2014; 253:1-15.

How to Cite This Article: Ghazavi A, Tonekaboni SH, Karimzadeh P, Nikibakhsh AA, Khajeh A, Fayyazi A. The Ketogenic and Atkins Diets Effect on Intractable Epilepsy: A Comparison. Iran J Child Neurol. 2014 Summer;8(3): 12-17.

Abstract

Objective
Intractable epilepsy is a major difficulty in child neurology, because the numbers of drugs that are available for treatment are limited and new treatments such as diets must be tried. Now there are some diets available for treating patients with intractable epilepsy. The oldest diet is the classic ketogenic diet and one of the
newest diets is the modified Atkins diet. Patients have a harder time accepting the classic ketogenic diet than the Atkins diet, which is easier to accept because the food tastes better. This study compares the efficacy of the ketogenic diet and the Atkins diet for intractable epilepsy in children.

Materials & Methods
This study is a clinical trial survey with sample size of 40 children with refractory epilepsy who were patients at Mofid hospital in Tehran, Iran. Initially, from Jan 2005–Oct 2007, 20 children were treated with the Atkins diet, and then from Oct 2007–March 2010, the other group was treated with the classic ketogenic diet and the results were compared. 

Results
In this study, response to treatment was greater than a 50% reduction in seizures and at the end of first, second, and third months for the ketogenic diet were 55%, 30%, and 70% and for the Atkins diet were 50%, 65%, and 70%, respectively.

Conclusion
The results of this study show that there is no significant difference between the classic Ketogenic diet and the Atkins diet at the end of first, second, and third months and both had similar responses to the treatments.

References 

1. Camfield CS, Canfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescents in Nova Scotia. Epilepsia, 1996 Jan;37(1):19-23.
2. Gessner U, Sagmeister M, Horisberger B. The cost of Epilepsy in Switzerland. Int J Health Sci 1993;4:121-8.
3. Aicardi J. Epilepsy in children. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 38.
4. 4. Kossof EH. More fat and fewer seizures: dietary therapy ofepilepsy. Lancet Neurol 2004 Jul;3()7):415-20.
5. Hassan AM, Keene DL, Whiting SE, Jacob PJ, Champagne JR, Humphreys P. Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr. Neurol. 1999; 21: 548-552.
6. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998 Nov;55(11):1433-7.
7. Nordli DR, Kuroda MM. Experience with the ketogen diet in infants. Pediatrics 2001 Jun; 108(1):129-33.
8. Tonekaboni SH, Mostaghimi P, Mirmiran P, Abbaskhanian A, Abdollah GF, Ghofrani M, et al. Efficacy of Atkins diet as therapy for intractable epilepsy in children. Arch Iran Med 2010 Nov;13(6):492-7.
9. Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia 2008 Nov;49 Suppl 8:37-41.
10. Mirjavadi SAR, Tonekaboni SH, Ghazavi MR, Azarghashb E, Abdollah GF, Ghofrani M. Efficacy of ketogenic diet as a therapy for intractable epilepsy in children. Iran J Child Neurol 2010 Sep;4(2):27-36.
11. Karimzadeh P, Tabarestani S, Mahvelati F, Tonekaboni SH, Ghofrani M. Intractable seizure disorfes; efficacy of the classic ketogenic diet. Iran J Child Neurol 2009 Jan; 3(1):15-20.
12. Barzegar M, Ostad Rahimi AR, Eslampour Sh, Shabazi Sh. The Ketogenic diet for refractory epilepsy. Med J Tabriz Uni Med Sci Health Serv 2009;31:15-20.
13. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics 2000 Apr;105(4):105-9.
14. Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol 2006 Jul;35(1):1-5.
15. Porta N, Vallee L, Boutry E, Fontaine M, Dessein AF, Joriot S, et al. Comparsion of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure 2009 Jun 18(5):359-64.

How to Cite This Article: Fallah R, Tirandazi F, Ferdosian F, Fadavi N. Iron Deficiency And Iron Deficiency Anemia in Children With First Attack of Seizure and on Healthy Control Group : A Comparative Study. Iran J Child Neurol. 2014 Summer;8(3): 18-23.

Abstract
Objective
Seizures are the most common pediatric neurologic problem. Research of the association between iron deficiency and seizures has shown conflicting results.
This study evaluates iron status of children with a first seizure attack (febrile seizure (FS) or first unprovoked afebrile seizure (FUS) and healthy control group.

Materials & Methods
In a cross sectional case control study, iron status of 6–60 month year old admitted children with first seizure to Shahid Sadoughi Hospital from August 2011–December 2012 were evaluated and compared with healthy control children that were referred to primary health care center of Azadshar, Yazd, Iran.

Results
150 children were compared in three equal (FS, afebrile seizure, and control) groups.
Hemoglobin levels in FUS (11.39 ± 1.07 g/dl) and FS (11.46 ± 1.18 g/dl) were lower than the control group (11.9 ± 0.89 g/dl) group.
Serum iron levels in FS (38.52 ± 11.38 μg/dL) and FUS (42.68 ± 14.76 μg/dL) were lower than the control group (54.32 ± 13.46 μg/dL).
Serum ferritin level in FUS (46.21 ± 27.63 ng/mL) and FS (48.91 ±22.96 ng/mL) was lower than the control group (75.13 ± 35.57 ng/mL).
Iron deficiency (48% in FS, 44% in FUS and 28% in control group) and iron deficiency anemia (26% in FUS, 22% in FS, and 10% in healthy children) was more frequent in children with seizures.

Conclusion
Iron status should be evaluated in children with a first attack of febrile or afebrile seizures.

References

1. Mikati MA. Seizures in Childhood. Kliegman RM, Stanton BF, Schor NF, St. Geme JW, Behrman RE. Nelson Textbook of Pediatrics. Philadelphia, Saunders 2011; 19^th edition, Pp: 2013-2017.
2. Yadav D, Chandra J. Iron deficiency: beyond anemia. Indian J Pediatr 2011;78(1):65-72.
3. Johnston MV. Iron deficiency, febrile seizures and brain development. Indian Pediatr 2012;49(1):13-4.
4. Idro R, Gwer S, Williams TN, Otieno T, Uyoga S, Fegan G, Kager PA, Maitland K, Kirkham F, Neville BG, Newton CR. Iron deficiency and acute seizures: results from children living in rural Kenya and a meta-analysis. PLoS One 2010 16; 5(11):e14001.
5. Carvalho AG, Lira PI, Barros Mde F, Aléssio ML, Lima Mde C, Carbonneau MA, Berger J, Léger CL. Diagnosis of iron deficiency anemia in children of Northeast Brazil. Rev Saude Publica. 2010; 44(3):513-9.
6. Kumari PL, Nair MK, Nair SM, Kailas L, Geetha S. Iron deficiency as a risk factor for simple febrile seizures—a case control study. Indian Pediatr 2012; 49(1):17-9.
7. Van Vranken M. Evaluation of microcytosis. Am Fam Physician 2010; 82(9):1117-22.
8. Morales-Ruán Mdel C, Villalpando S, García-Guerra A, Shamah-Levy T, Robledo-Pérez R, Avila-Arcos MA, Rivera JA. Iron, zinc, copper and magnesium nutritional status in Mexican children aged 1 to 11 years. Salud Publica Mex 2012; 54(2):125-34.
9. Modaresi M, Mahmoudian T, Yaghini O, Kelishadi R, Golestani H, Tavasoli A, et al. Is Iron Insufficiency Associated With Febrile Seizure? Experience in an Iranian Hospital. J Compr Ped 2012; 3(1):21-4.
10. Zareifar S, Hosseinzadeh HR, Cohan N. Association between iron status and febrile seizures in children. Seizure 2012; 21(8):603-5.
11. Akbayram S, Cemek M, Büyükben A, Aymelek F, Karaman S, Yilmaz F, Dogan M, Caksen H. Major and minor bio-element status in children with febrile seizure. Bratisl Lek Listy 2012; 113 (7):421-3.
12. Vaswani RK, Dharaskar PG, Kulkarni S, Ghosh K. Iron deficiency as a risk factor for first febrile seizure. Indian 2010; 47(5):437-9.
13. Sherjil A, us Saeed Z, Shehzad S, Amjad R. Iron deficiency anaemia--a risk factor for febrile seizures in children. J Ayub Med Coll Abbottabad. 2010; 22(3):71-3.
14. Naveed-ur-Rehman, Billoo AG. Association between iron deficiency anemia and febrile seizures. J Coll Physicians Surg Pak 2005; 15(6):338-40.
15. Hartfield DS, Tan J, Yager JY, Rosychuk RJ, Spady D, Haines C, Craig WR. The association between iron deficiency and febrile seizures in childhood. Clin Pediatr (Phila) 2009; 48 (4):420-6.
16. Derakhshanfar H, Abaskhanian A, Alimohammadi H, Modanloo KM. Association between iron deficiency anemia and febrile seizure in children. Med Glas Ljek komore Zenicko-doboj kantona. 2012; 9(2):239-42.
17. Bidabadi E, Mashouf M. Association between iron deficiency anemia and first febrile convulsion: A casecontrol study. Seizure 2009; 18(5):347-51.
18. Abaskhanian A, Vahid Shahi K, Parvinnejad N. The association between iron deficiency and the first episode of febrile seizure. J Babol Univ Med Sci 2009, 11 (3);32-36.(in Persian)
19. Kobrinsky NL, Yager JY, Cheang MS, Yatscoff RW, Tenenbein M. Does iron deficiency raise the seizure threshold? J Child Neurol 1995; 10(2):105-9.
20. Talebian A, Momtazmanesh N, Moosavi SGH, Khojasteh MR. The relationship between anemia and febrile seizure in children under 5 years old. Iran J Pediatr 2006; 16(1): 79-82.
21. Momen A, Hakimzadeh M. Case-control study of the relationship between anemia and febrile convulsion in children between 9 months to 5 years of age. Ahwaz Univ Med Sci 2003; 35: 50-4. [in Persian]
22. Salehiomran MR, Tamaddoni A, Nasehi MM, Babazadeh H, Alizadeh navaei R. Iron status in febrile seizure: a case-control study. Iranian Journal of Child Neurology (IJCN) 2009; 3 (3):39-42.
23. Amirsalari S, Keihani doust ZT, Ahmadi M, Sabouri A, Kavemanesh Z, Afsharpeyman S, Torkaman M, Ghazavi Y. Relationship between iron deficiency anemia and febrile seizures. Iranian Journal of Child Neurology (IJCN) 2010; 4(1):27.30.
24. Iranmanesh F, Shafa M.A, Nikian Y.A, Ahmadi Kohanali J. The association of serum iron, serum ferritin and TIBC with primary tonic- clonic seizures. Iranian Journal of Neurology 2005; 3(9):6-11.
25. Asadi-Pooya AA, Ghetmiri E. Red blood cell indices in children with idiopathic epilepsy: A case-control study. Clin Neurol Neurosurg 2006; 108(6):614-5.
26. Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, et al. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 2006; 64: S72–91.

How to Cite This Article: Mahyar A, Ayazi P, Dalirani R, Gholami N, Daneshi-Kohan MM, Mohammadi N, Ahmadi MM, Sahmani AA. Melatonin’s Effect in Febrile Seizures and Epilepsy Iran J Child Neurol. 2014 Summer;8(3): 24-29.

Abstract
Objective
Recognition of risk factors for febrile seizures (FS) and epilepsy is essential. 
Studies regarding the role of melatonin in these convulsive disorders are limited.
This study determines the relationship between serum melatonin levels and FS and epilepsy in children.

Materials & Methods
A population of 111 children with simple FS, complex FS, and epilepsy (37 children per group, respectively) were included as case groups. In addition, 37 febrile children without seizures comprised the control group. Serum melatonin levels were measured and compared between all groups.

Results
The serum melatonin levels in the simple, complex FSs, and epilepsy groups were 2, 2.4, and 2 pg/ml, respectively. The serum melatonin level in the control group was 2.1pg/ml.
Moreover, there were no significant differences observed while comparing the case groups.

Conclusion
The present study reveals that there is no association between serum melatonin level and simple or complex FS and epilepsy. It appears that melatonin plays no significant role in these convulsive disorders.

References

1. Banerjee TK, Hazra A, Biswas A, Ray Jet al. Neurological disorders in children and adolescents. Indian J Pediatr2009; 76:139-46.
2. Salehi Omran MR, Khalilian E, Mehdipour E, Ghabeli JA. Febrile seizures in North Iranian children: Epidemiology and clinical feature, Journal of Pediatric Neurology2008, 6: 39-43.
3. Shinnar S, O’Dell C. Febrile Seizures, Pediatr Ann 2004, 33: 394-402.
4. Millar JS. The child with febrile seizure, Pediatrics for parents 2006.24:12-14.
5. Fetvei A. Assessment of febrile seizures in children, Eur J Pediatr2008, 167:17-27.
6. Mikati MA. Seizures in Childhood In: Kliegman RM, Stanton BF, Schor NF, St. Geme III JW, Behrman RE. Nelson textbook of pediatrics. 19th ed. Phila: Saunders, 2011:2013-2039.
7. Camfield PR, Canfield CS. Epilepsy. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric neurology: principles and practice. 4th ed. Philadelphia: Mosby, 2006:981-8.
8. Chang BS, Lowenstein DH. Epilepsy, N Eng J Med 2003, 13:1257-1266.
9. Aydin A, Ergor A, Ergor G, Dirik E. The prevalence of epilepsy amongst school children in Izmir, Turkey, Seizure 2002; 11: 392–396.
10. 10.Jan MM, Girvin JP. Febrile seizures. Update and controversies. Neurosciences (Riyadh) 2004; 9:235-42.
11. French JA. Febrile seizures: possible outcomes. Neurology2012; 28; 79:e80-2.
12. Guo JF,Yao JF. Serum melatonin levels in children with epilepsy or FS, Zhongguo Dang Dai Er Ke Za Zhi2009, 11:288-90 (Medline).
13. Reiter RJ. Melatonin: clinical relevance, Best Pract. Res Clin Endocrinol Metab 2003, 17: 273-285.
14. Seithikurippu R, Perumal P, Trakh I, Srinivasan V, Spence DW, Maestroni GJM, Zisapel N, Cardinali DP. Physiological effects of melatonin Role of melatonin receptors and signal transduction pathways, Prog Neurobiol 85, 2008: 335-353.
15. Ardura J, Andres J, Garmendia JR, Ardura F. Melatonin in epilepsy and FS.J Child Neurol 2010; 25:888-91.
16. Ganesh R, Janakiraman L, Meenakshi B. Serum zinc levels are low in children with simple FS compared with those in children with epileptic seizures and controls.Ann Trop Paediatr 2011; 31:345-9.
17. Bazil CW, Short D, Crispin D, Zheng W. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology 2000; 55:1746-8.
18. Yalyn O, Arman F, Erdogan F, Kula M. A comparison of the circadian rhythmsand the levels of melatonin in patients with diurnal and nocturnal complexpartial seizures. Epilepsy Behav 2006;8:542-6.
19. Schapel GJ, Beran RG, Kennaway DL, McLoughney J, Matthews CD. Melatonin response in active epilepsy. Epilepsia 1995; 36:75-8.
20. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance,Biomedicine and Pharmacotherapy 2006,60: 97-108.
21. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, et al. Melatonin: a hormone, a tissue factor, an autacoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-8.
22. Allegra M, Reiter RJ, Tan DX, Gentile C, et al. The chemistry of melatonin’s interaction with reactive species.
23. J Pineal Res 2003; 34:1-10.
24. Rodriguez C, Mayo JC, Sainz RM, Antolin I, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
25. Tan DX, Reiter RJ, Manchester LC, Yan M.T et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger, Curr Top Med Chem2002, 2:181-197.
26. Molina-Carballo A, Munoz-Hoyos A, Sanchez-Forte M, Uberos-Fernandez J,Moreno-Madrid F, Cuna-Castroviejo D. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations, Neuropediatrics 2007; 38:122–5.
27. Molina-Carballo A, Acuña-Castroviejo D, Rodríguez- Cabezas T, Muñoz-Hoyos A. Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentration in children. J Pineal Res 1994; 16: 1-9
28. Rao ML, Stefan H, Bauer J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 1989; 49:33-9.
29. Fauteck J, Schmidt H, Lerchl A, Kurlemann G, Wittkowski W. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept 1999; 8:105–10.
30. Peled N, Shorer Z, Peled E, Pillar G. Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia 2001; 42:1208–10.
31. Coppola G, Iervolino G, Mastrosimone M, La TG, et al. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial. Brain Dev 2004; 26:373-6.

How to Cite This Article: Delpisheh A, Veisani Y, Sayehmiri K, Fayyazi A. Febrile Seizures: Etiology, Prevalence, and Geographical Variation. Iran J Child Neurol. 2014 Summer; 8(3):30-37.

Abstract
Objective
Febrile seizures (FSs) are the most common neurological disorder observed in the pediatric age group. The present study provides information about epidemiological and clinical characteristics as well as risk factors associated with FS among Iranian children.

Materials & Methods
On the computerized literature valid databases, the FS prevalence and 95% confidence intervals were calculated using a random effects model. A metaregression analysis was introduced to explore heterogeneity between studies. 

Data manipulation and statistical analyses were performed using Stata10.

Results
The important viral or bacterial infection causes of FSs were; recent upper respiratory infection 42.3% (95% CI: 37.2%–47.4%), gastroenteritis21.5% (95% CI: 13.6%–29.4%), and otitis media infections15.2% (95% CI: 9.8%- 20.7%) respectively. The pooled prevalence rate of FS among other childhood convulsions was 47.9% (95% CI: 38.8–59.9%). The meta–regression analysis showed that the sample size does not significantly affect heterogeneity for the factor ‘prevalence FS’.

Conclusions
Almost half of all childhood convulsions among Iranian children are associated with Febrile seizure.

References

1. Felipe L, Siqueira M. febrile seizures: update on diagnosis and management. Siqueira LFM. 2010;56 (4):489–92.
2. Oka E, Ishida S, Ohtsuka Y, Ohtahara S. Neuroepidemiological Study of Childhood Epilepsy by Application of International Classification of Epilepsies and Epileptic Syndromes (ILAE, 1989). Epilepsia. 1995;36 (7):658–61.
3. Shi X, Lin Z, Ye X, Hu Y, Zheng F, Hu H. An epidemiological survey of febrile convulsions among pupils in the Wenzhou region. Zhongguo Dang Dai Er Ke Za Zhi. 2012 Feb;14 (2):128–30.
4. Waruiru C, Appleton R. Febrile seizures: an update. Arch Dis Child. 2004;89 (8):751–6.
5. Bettis DB, Ater SB. Febrile seizures: Emergency department diagnosis and treatment. The Journal of Emergency Medicine. 1985;2 (5):341–8.
6. Bauchner H, Philipp B, Dashefsky B, Klein J. Prevalence of bacteriuria in febrile children. Pediatr Infect Dis J. 1987;6 (3):239–42.
7. Lee P, Verrier Jones K. Urinary tract infection in febrile convulsions. Arch Dis Child. 1991;66 (11):1287–90.
8. Fukuyama Y, Seki T, Ohtsuka C, Miura H, Hara M. Practical guidelines for physicians in the management of febrile seizures. Brain and Development. 1996;18 (6):479–84.
9. Mohebbi M, Holden KR. Febrile and afebrile or provoked and unprovoked seizures? Pediatric Neurology. 2005;32 (4):291.
10. Fallah R, Karbasi S. Recurrence of febrile seizure in Yazd, Iran. Turk J Pediatr ;52 (6):618–22. 2010 Nov–Dec;52 (6):618–22.
11. Ghotbi N, Soleimani S. Causes of seizures in children 1 month to 12 years. Journal Of Medical Sciences Kurdistan. 2002;7 (25):32–6.
12. Golestani M, Fallah R, Akhavan Krbasi S. Hundred cases of cerebrospinal fluid in children hospitalized due to febrile seizures. Journal of Yazd Medical Sciences 2008;16 (5):3–7.
13. Hassanpoor H, Ghofrani M, Taheri N, Ziaee A. Risk factors in the recurrence of seizures with fever. Journal of Iran Medical Sciences 2009;16 (65):46–54.
14. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness–based stress reduction and health benefits: A meta–analysis. Journal of Psychosomatic Research. 2004;57 (1):35–43.
15. Ades AE, Lu G, Higgins JP. The Interpretation of Random–Effects Meta–Analysis in Decision Models. Medical Decision Making. 2005;25 (6):646–54.
16. Ahmadian M, Javadi N. Etiologic factors and risk factors in 211 patients with seizure. Hormozgan Med J. 1996;12 (2):145–8.
17. Amini A, Kazemi A, Ghorbani A. Causes of Seizures in Children. Iran J Neurol. 2008;7 (24):355–60.
18. Ashrafzadeh F, hashemzadeheh A, Malek A. Febrile seizure in children six months to six years. Iranian Journal of Otorhinolaryngology. 2001;16 (1 (35)):33–9.
19. Barzegar M, karegar maheM, KivanchehN. Epidemiologic and clinical characteristics of seizures in children with first febrile attack. Med J Tabriz Univ Med Sci. 2006;28
20. (1):17–21.
21. Dehdashtian M, Momen AA, Ziae T, Moradkhani SH. Evaluation of seizure etiology in convulsive neonates admitted to Imam Khomeini and Abozar hospitals of Ahvaz 2004–2007. Jundishapur Sci Med J. 2009;8 (2):163–7.
22. Ehsanypoor F, Khdapnahndh F, Aslani Z. The frequency of meningitis in children hospitalized with febrile seizures. Iran J Med Sci. 2004;11 (44):907–12.
23. Fallah R, Akhavan Krbasi S, Mir–Nasseri F. Demographic and clinical characteristic children with first febrile seizure. Journal of Yazd Medical Sciences 2008;16 (5):65–1
24. Hosseininasab A, Daiparizzi M–H, Alidosti K. Demographic characteristics and risk factors of febrile seizure. J Med Counc IR Iran. 2006;24 (2):107–12.
25. Kazemi A, Mousavi Nasab N, Fatemi K. Cerebrospinal fluid examination in children hospitalized. Journal Of Medical Sciences Zanjan. 2001;9 (35):32–6.
26. Khazai T, Hossein Zadeh A, Javadzadeh M. Causes of seizures in children. Journal of Birjand Medical Sciences 2007;14 (4):45–52.
27. Khodapanahhandeh F. Studied 107 children with febrile seizures. Journal ofIran Medical Sciences. 2001;8 (25):175–8.
28. Moayedi AR, Nazemi Qshmy A, Safdarian F. Epidemiology and etiology of seizures and fever in children. Hormozgan M J. 2005;9 (3):153–6.
29. Mohammadi J. Biochemical Disorders in Children with Febrile Seizure. Scientific Jour of Ilam Med University. 2008;16 (4):1–6.
30. Namakin K, Shryfzadh G, Rezaei S. Demographic and clinical features febrile seizures. Journal of Birjand Medical Sciences 2010;17 (4):281–7.
31. Rasoli M, Moghimian A. Causes of fever in children with febrile seizures in children’s hospital. Journal of Babol University of Medical Sciences. 1999;10 (3):131–7.
32. Sadeghzadeh M, Asl P, Mousavi–Nasab N, kosha A, Pakdel M. Relationship between serum zinc levels and febrile seizure. Journal of Medical Science Zanjan. 2011;19 (74):17–24.
33. Talebian A, Momtazmanesh N, Mousavi GH, Khojasteh M. Relationship between febrile seizure and anemia. Iran J Pediatr. Mar 2006;16 (1):79–86.
34. Najaf–Zadeh A, Dubos F, Hue V, Pruvost I, Bennour A, Martinot A. Risk of bacterial meningitis in young children with a first seizure in the context of fever: a systematic review and meta–analysis. PLoS One. 2013;8 (1):1–8.
35. Eseigbe E, Eseigbe P, Adama S. Febrile seizures in Kaduna, north western Nigeria. Niger Med J. 2012;53(3):140–4.
36. Offringa M, Bossuyt PMM, Lubsen J, Ellenberg JH, Nelson KB, Knudsen FU, et al. Risk factors for seizure recurrence in children with febrile seizures: A pooled analysis of individual patient data from five studies. The Journal of Pediatrics. 1994;124 (4):574–84.
37. Sampaio LP, Caboclo LO, Kuramoto K, Reche A, Yacubian EM, Manreza M. Prevalence of Epilepsy in Children From a Brazilian Area of High Deprivation. Pediatr Neurol. 2010 Feb;42 (2):111–7.
38. van Zeijl JH, Mullaart RA, Borm GF, Galama JMD. Recurrence of febrile seizures in the respiratory season is associated with influenza A. The Journal of Pediatrics. 2004;145 (6):800–5.
39. Berg A, Shinnar S, Hauser W, Leventhal J. Predictors of recurrent febrile seizures: a metaanalytic review. J pediater. 1990 Mar;116 (3):329–37.
40. Berg AT. Risk of recurrence after a first unprovoked seizure. Epilepsia. 2008;49 (Suppl 1):13–8.
41. Teach S, Geil P. Incidence of bacteremia, urinary tract infections, and unsuspected bacterial meningitis in children with febrile seizures. Pediatr Emerg Care. 1999;15 (1):9–12.

How to Cite This Article: Saeed M, Azam M, Shabbir N, Qamar ShA. Is "Benign Childhood Epilepsy with Centrotemporal Spikes" Always Benign? Iran J Child Neurol. 2014 Summer;8(3): 39-45.

Abstract
Objective
To determine the prevalence of associated behavioral problems and prognosis with Benign Childhood Epilepsy with CentroTemporal Spikes (BCECTS).
Descriptive, Cross Sectional study that was conducted from October 2009 to April 2013 in the Department of Pediatric Neurology, the Children’s Hospital Taif, KSA.

Material & Methods
This study was conducted after approval from the Ethics Committee of the Children’s Hospital Taif, Saudi Arabia. Thirty-two patients from the age of 3 to 10 years old were recruited from the pediatric neurology clinic over a period of 4 years. All the patients were selected based on history, EEGs, and neuropsychological and neurological examinations.
EEGs were performed for all the patients while in awake and sleep states. Those who had centrotemporal discharges were included in the study. All the patients also underwent a brain MRI. Only two patients had mild cortical atrophy but developmentally they were normal.

Results
In our study, prevalence of BRE is 32/430 (7.44%). Among the 32 cases, 24 were male and eight were female. Six cases out of 32 indicated a family history of BRE. Twenty-eight cases had unilateral right sided centrotemporal discharges and four had bilateral discharges.

Conclusion
It is possible that for BECTS, a high number of seizures might play an important role in the development of mild cognitive impairment and/or behavior disturbances.

References

1. Bradley WG, Daroff RB, Fenichel JM, Jahrovic J. Neurology of clinical practice. 5th Ed. 2009: pp. 1953-1990.
2. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross H, Van Emde Boas M, et al: Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010; 51(4):676-685.
3. Weglage J, Demsky A, Pietsch M. Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures. Dev Med Child Neurol. 1997; 39:646.
4. Kramer U. Atypical presentations of benign childhood epilepsy with centrotemporal spikes: a review. 2008. J. Child Neurol 23 (7): 785–90.
5. Chahine LM, Mikati MA. Benign pediatric localizationrelated epilepsies. Epileptic Disord. 2006. 8(4): 243–58.
6. Danielsson J, Petermann F. Cognitive deficits in children with benign rolandic epilepsy of childhood or rolandic discharges: a study of children between 4 and 7 years of age with and without seizures compared with healthy controls. Epilepsy Behav. 2009; 16:646–651.
7. Ay Y, Gokben S, Serdaroglu G, Polat M, Tosun A, Tekgul H, et al. Neuropsychologic impairment in children with rolandic epilepsy. Pediatr Neurol. 2009; 41:359–363.
8. Wirrell E, Sherman EM, Vanmastrigt R, Hamiwka L. Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame. J Child Neurol. 2008; 23:14–21.
9. Lundberg S, Eeg-Olofsson O. Rolandic epilepsy: a challenge in terminology and classification, European Journal of Paediatric Neurology. 2003; 7: 239–241.
10. Bouma PA, Bovenkerk AC, Westendorp RG, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48:430-437.
11. Deltour L, Quaglino V, Barathon M, De Broca A, Berquin P. Clinical evaluation of attentional processes in children with benign childhood epilepsy with centrotemporal spikes (BCECTS) Epileptic Disord. 2007; 9:424–431.
12. Nicolai J, Aldenkamp AP, Arends J, Weber JW, Vles JS. Cognitive and behavioral effects of nocturnal epileptiform discharges in children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav. 2006; 8:56–70.
13. Goldberg-Stern H, Gonen OM, Sadeh M, Kivity S, Shuper A, Inbar D. Neuropsychological aspects of benign childhood epilepsy with centrotemporal spikes. Seizure. 2010; 19:12–16.
14. Genizi J, Shamay-Tsoory SG, Shahar E, Yaniv S, Aharon- Perez J. Impaired social behavior in children with benign childhood epilepsy with centrotemporal spikes. J Child Neurol. 2012; 27:156–161.
15. Zenkov LR, Konstantinov PA, Shiriaeva IIu, Miasnikov VN, Sirazitdinova EB, Shevel’chisnkiĭ SI. Mental and behavioral disorders in idiopathic focal epileptiform spikes. Zh Nevrol Psikhiatr Im S Korsakova. 2007; 107:39–49.
16. Winckler MIB, Rotta NT. Prognostic factors for recurrence of a first seizure during childhood. Arq Neuropsiquiatr.1997; 55:749-756.
17. Holmes GL. Rolandic epilepsy: clinical and electroencephalographic features. In: Degen R, Dreifuss FE, editors. Benign localized and generalized epilepsies of early childhood. Amsterdam: Elsevier ;1992: p.29-43.
18. Gregory DL, Wong PKH. Clinical relevance of a dipole field in rolandic spikes. Epilepsia. 1992; 33:36-44.
19. Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta- analysis. Neurology. 1997; 48: 430-437.
20. Fejerman N, Caraballo R, Tenembaum S. Atypical evolutions of benign -localization-related epilepsies in children: are they predictable? Epilepsia. 2000; 4: 380-390.
21. Peters JM, Camfield CS, Camfield PR. Population study of benign rolandic epilepsy: is treatment needed? Neurology. 2001; 57: 537-539.
22. Holmes GL. Rolandic epilepsy: clinical and electroencephalographic features. In Degen R, Dreifuss FE. editors. Benign localized and generalized epilepsies of early childhood. Amsterdam: Elsevier 1992:p. 29-43.
23. Laub MC, Funke R, Kirsch CM, Oberst U. BECT: comparison of cerebral blood flow imaging, neuropsychological testing and long-term EEG findings. Epilepsy Res Suppl. 1992;6:95-98.
24. Coppola G. Cognitive and linguistic abnormalities in benign childhood epilepsy with centrotemporal spikes. Acta Paediatr. 2011;100(5):768-772.
25. Sarco DP, Boyer K, Lundy-Krigbaum SM, Takeoka M, Jensen F, Gregas M, Waber DP. Benign rolandic epileptiform discharges are associated with mood and behavior problems. Epilepsy Behav. 2011;22 (2):298-303.
26. Jones JE, Watson R, Sheth R, Caplan R, Koehn M, Seidenberg M, et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol. 2007;49:493-7.
27. Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics. 2001; 107:115-22.
28. Bhise VV, Burack GD, Mandelbaum DE. Baseline cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Dev Med Child Neurol. 2010;52:22-6.
29. Kavros PM, Clarke T, Strug LJ, Halperin JM, Dorta NJ, Pal DK. Attention impairment in rolandic epilepsy: systematic review. Epilepsia. 2008; 49:1570-80.
30. Beaussart M. Benign epilepsy of children with Rolandic (centro-temporal) paroxysmal foci: A clinical entity: Study of 221 cases. 1972. Epilepsia 13 (6): 795–811.

How to Cite This Article: Ghaffari J, Abbaskhanian A, Jalili M, Yazdani Charati Y. IQ Score of Children With Persistent or Perennial Allergic Rhinitis: Comparison with Healthy Children. Iran J Child Neurol. 2014 Summer; 8(3): 44-48.

Abstract
Objective
Prevalence of allergies is different around the world. Allergic rhinitis is a common chronic disease in children.
Intelligence quotient (IQ) is an indicator of efficacy and many factors including chronic diseases may affect it. This study compares the IQs of children diagnosed with persistent or perennial allergic rhinitis with healthy children.

Material & Methods
This was a comparative study that was conducted from June 2011–May 2013 in an academic referral clinic. In this study, 90 patients aged 6- to 14-yearsold who were diagnosed with persistent or perennial allergic rhinitis and were compared to 90 age and gender match healthy patients from their respective families. The Wechsler Intelligence Scale for hildren was used to divide and calculate overall IQ, verbal IQ, and practical IQ. The t-test and chi square were used to analyze quantitative variables and qualitative variables, respectively.

Results 

In this study, out of total 180 children, 90 (50%) in the case group and 90 children (50%), the control group participated for IQ comparison. One hundred (57%) were male and 80 (43%) were female. The overall IQ for allergic rhinitis patients and healthy patients was 109.2 and 107.5, respectively. This difference was not considered significant. Furthermore, there was no significant difference between the IQ scores of males and females.

Conclusion
Although allergic rhinitis is a chronic disease and effects quality of life, there were no identifiable negative effects on IQ. 

References

1. Ghaffari J, Mohammadzadeh I, Khaliian A, Rafatpanah H, Mohammadjafari H, Davoudi A. Prevalence of asthma, allergic rhinitis and eczema in elementary schools in Sari(Iran). Caspian Journal of Internal Medicine. 2012; 3(1):372-76.
2. Mohammadzadeh I, Barari-Savadkoohi R, Alizadeh- Navaei R. The prevalence of allergic rhinitis in Iranian children: A systematic review and descriptive metaanalysis. Journal of Pediatrics Review. 2013; 1(2):19-24.
3. Ghaffari J. Prevalence of Aeroallergens in Skin Test of Asthma, Allergic Rhinitis, Eczema, and Chronic Urticaria Patients in Iran. Journal 0f Mazandaran University of Medical Sciences. 2012; 22(87): 139-151 (Persian).
4. Horn JL, Cattel RB. Refinement and test of the theory of fluid and crystallized intelligence. Journal of  ducational Psychology. 1966;57:253–70.
5. Black KC, Hynd GW. Epilepsy in the School aged child: Cognitive-Behavioral Characteristic and effect on Academic performance. School Psychology Quarterly. 1995;10:345–58.
6. Wolters PL, Brouwers P, Moss HA. Pediatric HIV disease: Effect on cognitive learning and behavior. School Psychol Quarterly. 1995;10:305–28.
7. Gutstadt LB, Gillette JW, Mrazek DA, Fukuhara JT, LaBrecque JF, Strunk RC. Determinants of school performance in children with chronic asthma. The American Journal of Diseases of Children. 1989;143:471–5.
8. Liesker JW, Postma DS, Beukema RJ, ten Hacken NH, van der Molen T, Riemersma RA, et al. Cognitive performance in patients with COPD. Respiratory Medicine. 2004;98:351–356.
9. Zhou G, Liu J, Sun F, Xin X, Duan L, Zhu X, Shi Z. Association of Chronic Obstructive Pulmonary Disease with Cognitive Decline in Very Elderly Men. Dementia and Geriatric Cognitive Disorders Extra. 2012 Jan-Dec; 2(1): 219–228. Published online 2012 May 22. doi: 10.1159/000338378.
10. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Annals of Allergy, Asthma & Immunology. 1993 Sep;71(3):251-8.
11. Groth-Marnat G. Handbook of psychological assessment. Wiley.4th ed. 2003:p.129-195.
12. Shahim S. Adaptation and Standardization of the Wechsler Intelligence Scale for children Revised. Shiraz University Press. 1373. p.5-94.
13. Marshall PS, O’Hara C, Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Annals of Allergy, Asthma & Immunology. 2000 Apr;84(4):403-10.
14. Bender BG. Are asthmatic children educationally handicapped? School Psychology Quarterly. 1995;10:274–91.
15. Ghaffari J, Abaskhanian A, Jalili M. IQ Score of Children with Moderate Asthma: Comparison with Healthy Children. Oman Medical Journal. 2014 Jan; 29(1):71-74.
16. Daramola OO, Ayoola OO, Ogunbiyi AO.The comparison of intelligence quotients of atopic and nonatopic children in Ibadan, Nigeria. Indian Journal of Dermatology. 2010 Jul-Sep;55(3):221-4. doi: 10.4103/0019-5154.70665.
17. Keremer B, Den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clinical & Experimental Allergy. 2002; 32:1310-1315.

How to Cite This Article: Kheradmand Z, Yarali B, Zare A, Pourpak Z, Shams S, Ashrafi MR. Comparison of Serum Zinc and Copper levels in Children and adolescents with Intractable and Controlled Epilepsy. Iran J Child Neurol. 2014; 8(3):49-54.

Abstract
Objective
Trace elements such as zinc and copper have physiological effects on neuronal excitability that may play a role in the etiology of intractable epilepsy. This topic has been rarely discussed in Iranian epileptic patients.
This study with the analysis of serum zinc and copper levels of children and adolescents with intractable and controlled epilepsy may identifies the potential role of these two trace elements in the development of epilepsy and intractability
to antiepileptic drug treatment. 

Materials & Methods
Seventy patients between the ages of 6 months to 15 years that referred to Children’s Medical Center with the diagnosis of epilepsy, either controlled or intractable to treatment enrolled in the study. After informed parental consent the levels of serum zinc and copper were measured with atomic absorption
spectrophotometer and analyzed with SPSS version 11.

Results
35 patients were enrolled in each group of intractable (IE) and controlled epilepsy (CE). 71.45% of the IE and 25.72% of the CE group had zinc deficiency that was statistically significant. 48.58% of the IE and 45.72 of the CE group were copper deficient, which was not statistically significant.

Conclusion
Our findings showed significant low serum zinc levels of patients with intractable epilepsy in comparison with controlled epilepsy group. 
We recommend that serum zinc level may play a role in the etiology of epilepsy and intractable epilepsy therefore its measurement and prescription may be regarded in the treatment of intractable epilepsy.

References

1. Mikati MA. Seizures in childhood. In: Kliegman RM, Stanton BF, Schor NF, Geme JWS, Behrman R (eds). Nelson textbook of pediatrics. 19th ed. Elsevier:Saunders; 2011. Pp.2013-2033.
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342: 314-9.
3. Patrick Kwan, Alexis Arzimanoglou, Anne T. Berg, et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069-1077.
4. Berg AT, Shinnar S, Levy SR, Testa F, Smith-Rapaport S, Beckerman B. Early development of intractable

epilepsy in children: a prospective study. Neurology 2001;56:1445-1452.

1. Haoa XT, Wong ISM, Kwan P. Interrater reliability of the international consensus definition of drug-resistant epilepsy: A pilot study. Epilepsy & Behavior 2011;22;388-390.
2.  Ashrafi MR, Mohseni M, Shams S, Shabanian R, Yekaninejad MS, et al. A Probable Causative Factor for an Old Problem: Selenium and Glutathione Peroxidase Appear to Play Important Roles in Epilepsy pathogenesis. Epilepsia 2007;48(9):1750-1755.
3. Liochev SI, Fridovich, I. Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase. J Biol Chem 2000; 275: 38482-38485.
4. Jacob RA. Trace Elements in textbook of Clinical Chemistry. WB Saunders, 1986. pp. 965-985.
5. Salwen MJ. Vitamis and Trace Elements. In: Pherson RA, Pincus MR (eds). Henry’s Clinical Diagnosis and Management By Laboratory Methods Tweny-First Edition. Saunders; 2007. Pp. 379-389.
6. Rokgauerj M, Klein J Kruse-Jarres J. D. Reference Values for the Trace Elements Copper, Manganese, Selenium, and Zinc in the Serum/ Plasma of Children, Adolescents, and Adults. J Trace Element Med Biol. 1997;11: 92-98.
7. Volpe SL, Schall JI, Gallagher PR, Stallings VA, Bergqvist AGC. Nutrient intake of children with intractable epilepsy compared with healthy children. Journal of the American Dietetic Association 2007;107(6):1014-8. Epub 2007/05/26.
8. Wojciak RW, Mojs E, Stanislawska-Kubiak M, Samborski W. The serum zinc, copper, iron, and chromium concentrations in epileptic children. Epilepsy Research 2013;104:40-44.
9. Hamed SA, Abdellah MM, El-Melegy N. Blood levels of trace elements, electrolytes, and oxidative stress/

antioxidant systems in epileptic patients. J Pharmacol Sci 2004;96:465-473.

1. Dudek FE. Zinc and epileptogenesis. Epilepsy Curr 2001; 1:66-70.
2. Mathie A, Sutton GL, Clarke CE, Veale EL. Zinc and copper: pharmacological probes and endogenous  modulators of neuronal excitability. Pharmacol Ther. 2006;111(3):567-83. Epub 2006/01/18.
3. Schrauzer GN. Selenomethionine and Selenium Yeast: Appropriate Forms of Selenium for Use in Infant Formulas and Nutritional Supplements. Journal of medicinal food 1998;1(3):201-6.
4. Seven M, Basaran SY, Cengiz M, Unal S. Deficiency of selenium and zinc as a causative factor For idiopathic intractable epilepsy. Epilepsy Research 2013;104 :35-39.

How to Cite This Article: Karimzadeh P, Jafari N, Nejad Biglari H, Jabbeh Dari S, Ahmad Abadi F, Alaee MR, Nemati H, Saket S,
Tonekaboni SH, Taghdiri MM, Ghofrani M. GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and Neuroimaging Findings (An Iranian Pediatric Case Series) Iran J Child Neurol. 2014 Summer;8(3): 55-60.

Abstract
Objective
GM2-Gangliosidosis disease is a rare autosomal recessive genetic disorder that includes two disorders (Tay–Sachs and Sandhoff disease).These disorders cause a progressive deterioration of nerve cells and inherited deficiency in creating
hexosaminidases A, B, and AB.

Materials & Methods
Patients who were diagnosed withGM2-Gangliosidosis in the Neurology Department of Mofid Children’s Hospital in Tehran, Iran from October 2009 to February 2014were included in our study. The disorder was confirmed by neurometabolic and enzyme level detection of hexosaminidases A, B, and AB
in reference to Wagnester Laboratory in Germany. We assessed age, gender, past medical history, developmental status, clinical manifestations, and neuroimaging findings of 9 patients with Sandhoff disease and 9 with Tay Sachs disease.

Results
83% of our patients were the offspring of consanguineous marriages. All of them had a developmental disorder as a chief complaint.
38%of patients had a history of developmental delay or regression and 22% had
seizures. The patients with Sandhoff and Tay Sachs disease were followed for approximately 5 years and the follow-up showed all patients were bedridden or had expired due to refractory seizures, pneumonia aspiration, or swallowing
disorders.
Neuro-imaging findings included bilateral thalamic involvement, brain atrophy, and hypo myelination in near half of our patients (48%). 

Conclusion
According to the results of this study, we suggest that cherry-red spots, hyperacusis, refractory seizures, and relative parents in children with developmental delay and/or regression should be considered for assessment of GM2-Gangliosidosis disease.

References

1. Yun YM, Lee SN. A case refort of Sandhoff disease. Korean journal of ophthalmology: KJO. 2005;19(1):68-72. Epub 2005/06/03.
2. O’Dowd BF, Klavins MH, Willard HF, Gravel R, Lowden JA, Mahuran DJ. Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). The Journal of biological chemistry. 1986;261(27):12680-5. Epub 1986/09/25.
3. Der Kaloustian VM, Khoury MJ, Hallal R, Idriss ZH, Deeb ME, Wakid NW, et al. Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon. American journal of human genetics. 1981;33(1):85-9. Epub 1981/01/01.
4. Cashman NR, Antel JP, Hancock LW, Dawson G, Horwitz AL, Johnson WG, et al. N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study. Annals of neurology. 1986;19(6):568-72. Epub 1986/06/01.
5. Oonk JGW, Van der Helm HJ, Martin JJ. Spinocerebellar degeneration: hexosaminidase A and B deficiency in two adult sisters. Neurology 1979;29:380–384.
6. Federico A, Ciacci G, D’Amore I, Pallini R, Palmeri S, Rossi A, et al. GM2 Gangliosidosis with Hexosaminidase A and B Defect: Report of a Family with Motor Neuron Disease-like Phenotype. In: Addison GM, Harkness RA, Isherwood DM, Pollitt RJ, editors. Practical Developments in Inherited Metabolic Disease: DNA Analysis, Phenylketonuria and Screening for Congenital Adrenal Hyperplasia: Springer Netherlands; 1986. p. 307-10.
7. Gomez-Lira M, Sangalli A, Mottes M, Perusi C, Pignatti PF, Rizzuto N, et al. A common beta hexosaminidase gene mutation in adult Sandhoff disease patients. Human genetics. 1995;96(4):417-22. Epub 1995/10/01.
8. Barbeau A, Plasse L, Cloutier T, Paris S, Roy M. Lysosomal enzymes in ataxia: discovery of two new cases of late onset hexosaminidase A and B deficiency (adult Sandhoff disease) in French Canadians. The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques. 1984;11(4 Suppl):601-6. Epub 1984/11/01.
9. Haghighi A, Masri A, Kornreich R, Desnick RJ. Tay- Sachs disease in an Arab family due to c.78G>A HEXA nonsense mutation encoding a p.W26X early truncation enzyme peptide. Molecular genetics and metabolism. 2011;104(4):700-2. Epub 2011/10/05.
10. Tay SK, Low PS, Ong HT, Loke KY. Sandhoff disease- a case report of 3 siblings and a review of potential therapies. Annals of the Academy of Medicine, Singapore. 2000;29(4):514-7. Epub 2000/11/01.
11. Ghosh M, Hunter WS, Wedge C. Corneal changes in Tay-Sachs disease. Canadian journal of ophthalmology Journal canadien d’ophtalmologie. 1990;25(4):190-2.Epub 1990/06/01.
12. Hittmair K, Wimberger D, Bernert G, Mallek R, Schindler EG. MRI in a case of Sandhoff’s disease. Neuroradiology. 1996;38 Suppl 1:S178-80. Epub 1996/05/01.
13. Koelfen W, Freund M, Jaschke W, Koenig S, Schultze C. GM-2 gangliosidosis (Sandhoff’s disease): two year follow-up by MRI. Neuroradiology. 1994;36(2):152-4.Epub 1994/01/01.
14. Kokot W, Raczynska K, Krajka-Lauer J, Iwaszkiewicz- Bilikiewicz B, Wierzba J. [Sandhoff’s and Tay-Sachs disease--based on our own cases]. Klinika oczna. 2004;106(3 Suppl):534-6. Epub 2005/01/08. Choroba Sandhoffa oraz Tay Sachsa--w oparciu o przypadki  wlasne.
15. Barness LA, Henry K, Kling P, Laxova R, Kaback M, Gilbert-Barness E. A 7-year old white-male boy with progressive neurological deterioration. American journal of medical genetics. 1991;40(3):271-9. Epub 1991/09/01.
16. Arisoy AE, Ozden S, Ciliv G, Ozalp I. Tay-Sachs disease: a case report. The Turkish journal of pediatrics. 1995;37(1):51-6. Epub 1995/01/01.
17. Ozkara HA, Topcu M, Renda Y. Sandhoff disease in the Turkish population. Brain & development. 1997;19(7):469-72. Epub 1997/12/31.

How to Cite This Article: Shetty G, Avabratha K.S, Rai B.S. Ring-Enhancing Lesions in the Brain: A Diagnostic Dilemma. Iran J Child Neurol. 2014 Summer;8(3): 61-64.

Abstract

The most common radiological abnormality seen in young Indian patients with epilepsy is single small enhancing (ring/disc) computed tomographic (CT) lesions. The two most common differential diagnosis of this lesion in clinical practice include neurocysticercosis (NCC) and tuberculomas. They have similar clinical and neuroimaging features. Few researchers believe that in poor and developing countries (where both tuberculosis and NCC are common) that it is difficult to differentiate between tuberculomas and a single cysticercal granulomas.

We report a case of a 6-year-old female patient who presented with complex partial seizures. The patient’s neuroimaging showed a single ring-enhancing lesion in the brain that was not differentiated between NCC and Tuberculoma.
Finally, Magnetic resonance spectroscopy (MRS) was suggestive of tuberculoma that was successfully treated with antituberculosis therapy.
This report highlights diagnostic difficulties with conventional investigations in single ring enhancing lesions in the brain and role of MRS in a diagnosis. MRS is helpful in differentiating these two conditions. 

References

1. Seth R, Kalra V, Sharma U, Jagannathan N. Magnetic resonance spectroscopy in ring enhancing lesions. Indian pediatrics. 2010;47(9):803-4. Epub 2010/11/05.
2. Rudresh K MKM, Karthik, Sebastin J. Clinical and Aetiological Profile of Ring-enhancing Lesions on CT Brain. Journal of Indian Academy of Clinical Medicine. 2008;9(2):100-2.
3. RK G. Single enhancing computerized tomography– detected lesion in immunocompetent patients. Neurosurg Focus 2002;12(6):1-9.
4. Singhi P RM. Focal seizure with single small ring enhancing lesion Seminars in Pediatric Neurology. 1999;6(3):196-201.
5. Sethi PP, Wadia RS, Kiyawat DP, Ichaporia NR, Kothari SS, Sangle SA, et al. Ring or disc enhancing lesions in epilepsy in India. The Journal of tropical medicine and hygiene. 1994;97(6):347-53. Epub 1994/12/01.
6. Jain AP JR, Lathia T. Single Small Enhancing Computed Tomography Lesion: A Review. Journal of Indian Academy of Clinical Medicine. 2005;6(2):114-21.
7. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC. Magnetic resonance spectroscopy. J Neuroophthalmol. 2005;25(3):217-26. Epub 2005/09/09.
8. Pretell EJ MCJ, Garcia HH, Alvarado M, Bustos JA, Martinot C. Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Assist Tomogr. 2005;29:112-4.
9. Santy K, Nan P, Chantana Y, Laurent D, Nadal D, Richner B. The diagnosis of brain tuberculoma by (1)H-magnetic resonance spectroscopy. Eur J Pediatr. 2011;170(3):379-87. Epub 2011/02/09.
10. Gutch M, Jain N, Agrawal A, Modi A. MR spectroscopy in tuberculoma of brain. BMJ Case Rep. 2012;2012. Epub 2012/05/19.

How to Cite This Article: Fayyazi A, Khajeh A. Does Electroencephalography Contribute to Examining Children with Attention Deficit Hyperactivity Disorder? Iran J Child Neurol. 2014 Summer;8(3): 65-67.

Letter to Editor, Has not abstract.

References

1. Swaiman Kenneth F AS, Ferriero D, Schor N. Pediatric neurology: principles & practice. 5th ed. Philadelphia: Elsevier/Saunders; 2012. p.622-628.
2. Sadock BJ, Sadock VA, Ruiz P, Kaplan HI. Kaplan & Sadock’s comprehensive textbook of psychiatry. 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009.p.3560-3579.
3. Parisi P, Moavero R, Verrotti A, Curatolo P. Attention deficit hyperactivity disorder in children with epilepsy. Brain & development. 2010;32(1):10-6. Epub 2009/04/17.
4. Laporte N, Sebire G, Gillerot Y, Guerrini R, Ghariani S. Cognitive epilepsy: ADHD related to focal EEG discharges. Pediatric neurology. 2002;27(4):307-11. Epub 2002/11/19.
5. Dunn DW, Kronenberger WG. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Seminars in pediatric neurology. 2005;12(4):222-8. Epub 2006/06/20.
6. Kattimani S, Mahadevan S. Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy. Annals of Indian Academy of Neurology. 2011;14(1):9-11. Epub 2011/06/03.
7. Holtmann M, Becker K, Kentner-Figura B, Schmidt MH. Increased frequency of rolandic spikes in ADHD children. Epilepsia. 2003;44(9):1241-4. Epub 2003/08/16.
8. Richer LP, Shevell MI, Rosenblatt BR. Epileptiform abnormalities in children with attention-deficithyperactivity disorder. Pediatric neurology. 2002;26(2):125-9. Epub 2002/03/19.
9. Marston D, Besag F, Binnie CD, Fowler M. Effects of transitory cognitive impairment on psychosocial functioning of children with epilepsy: a therapeutic trial. Developmental medicine and child neurology. 1993;35(7):574-81. Epub 1993/07/01.
10. Fonseca LC, Tedrus GM, Moraes C, Vicente Machado A, Almeida MP, Oliveira DO. Epileptiform abnormalities and quantitative EEG in children with attention-deficit/ hyperactivity disorder. Arquivos de neuro-psiquiatria. 2008;66(3A):462-7. Epub 2008/09/25.
11. Li L, Yang L, Zhuo CJ, Wang YF. A randomised controlled trial of combined EEG feedback and methylphenidate therapy for the treatment of ADHD. Swiss medical weekly. 2013;143:w13838. Epub 2013/08/30.
12. Hughes JR, DeLeo AJ, Melyn MA. The Electroencephalogram in Attention Deficit-Hyperactivity Disorder: Emphasis on Epileptiform Discharges. Epilepsy & behavior : E&B. 2000;1(4):271-7. Epub 2003/03/01.
13. Millichap JG, Millichap JJ, Stack CV. Utility of the electroencephalogram in attention deficit hyperactivity disorder. Clinical EEG and neuroscience. 2011;42(3):180-4. Epub 2011/08/30.
14. Matoth I, Taustein I, Kay BS, Shapira YA. Overuse of EEG in the evaluation of common neurologic conditions. Pediatric neurology. 2002;27(5):378-83. Epub 2002/12/31.
15. Lubar JF, Swartwood MO, Swartwood JN, O’Donnell PH. Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance. Biofeedback and self-regulation. 1995;20(1):83-99. Epub 1995/03/01.
16. Linden M, Habib T, Radojevic V. A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback and self-regulation. 1996;21(1):35-49. Epub 1996/03/01.